% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • ccharles792 ccharles792 Mar 12, 2013 4:49 PM Flag

    " US Market Launch Will generate Dramtic Shift In Longs Favor " Posted.

    A final clearance for take-off in the U.S. market for Arena's Belviq would likely be accompanied by renewed discussion of milestone payments and royalties. Arena is expected to receive $5.0 million from its marketing partner upon receiving a DEA designation and another $60 million upon Belviq's launch. Then royalties begin. Arena's CFO at one point suggested the first $1.0 billion in total sales could trigger royalties in excess of $300 million.
    Chatter about payments and cash flows along with the enthusiastic re-calculation of future revenue and
    profits are likely to generate a dramatic shift in sentiment, turning up the volume on Arena valuation and stock price. If that happens, it might be ARNA bears who are nibbling on their digits

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.63+0.01(+0.62%)May 24 4:00 PMEDT